Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects

NCT06861842 is registered in ClinicalTrials.gov with Centro de Atencion e Investigacion Medica as lead sponsor.

NCT NCT06861842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06861842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects
Lead sponsor
Centro de Atencion e Investigacion Medica
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 1, 2024
Completion date
April 30, 2025
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, healthy donors